BioSpring Empowers Your Therapeutic Innovations
Customized Solutions for Nucleic Acid Manufacturing and Analysis – From Research to Commercial Applications
Welcome to BioSpring, your trusted partner in advancing nucleic acid-based therapies. With nearly three decades of experience, we specialize in nucleic acid manufacturing and analytical services that are vital to the success of your drug development programs. From preclinical research to full-scale commercial production, we offer unparalleled quality, flexibility, and regulatory support, ensuring your therapies reach patients faster and with greater efficiency.
Early discovery through commercial cGMP therapeutic & diagnostic manufacturing
Multiple hundred kg annual manufacturing capacity, expansion to metric ton capacity until 2027
Global leader for the production of guide RNA for cell & gene therapy
(e.g. CRISPR/Cas)
Our Expertise:
Comprehensive Manufacturing Services
At BioSpring, we provide end-to-end manufacturing solutions for nucleic acids, covering everything from small-scale research production to large-scale commercial batches. Our FDA-inspected, GMP-compliant facilities guarantee the highest quality, while our innovative technologies ensure your programs are prepared for every phase of clinical development. Whether you're working with siRNAs, ASOs, guide RNAs, or other nucleic acids, our tailored processes are designed to meet your exact needs.
Covering the Entire Drug Development Lifecycle
- Manufacturing for Research & Development, lead screening, and lead optimization
- Custom manufacturing solutions and chemistries
- High-throughput manufacturing
- Early preclinical, mid-scale batch manufacturing
- Regulatory tox batch manufacturing
- Process development & scale-up
- Commercial manufacturing and process validation
- cGMP manufacturing for clinical phase I-III (ICH Q7)
- Process transfer and optimization
Cutting-Edge Analytical Services
For Drug Substance & Drug Product
The nucleic acid company
About BioSpring
BioSpring is a leading industry expert in nucleic acid science and technology, specializing in high-quality cGMP manufacturing and analytics for commercial programs and clinical phases I - III, in addition to preclinical material supply and diagnostic manufacturing. We are a privately owned company of over 650 employees committed to providing expert support through all phases and regulatory filings, including highly flexible and customizable solutions to accelerate therapeutic programs through the entire drug development lifecycle.
Headquartered in the center of Europe, in Frankfurt, Germany, we are an international company with a subsidiary in the United States and a local presence in Japan. Our global clients can rely on our quality and expertise, guided by our passion for innovation and three decades of experience. Our aim is a highly collaborative partnership to unleash the full potential of our clients’ technology, making great strides and breakthroughs possible.
Realize the full potential of your therapeutic nucleic acid programm!
Download our comprehensive brochure now and discover how BioSpring's advanced manufacturing and analytical solutions can take your project from concept to clinical sucess.
Brochure: Global Leader in Oligonucleotide Manufacturing & Analysis
